This Startup Is Changing Cancer Detection Around the World (featuring X-ZELL)
We probably have all been affected by cancer in some way, either directly or through our family and loved ones.
That is why we often keep a close eye on how innovation is elevating detection and cure within the industry. So when an email crossed our desk about a revolutionary detection method that is scalable, we decided to give it a look.
Fresh off their recent first place finish at the Asia Pacific Accelerator programme from MedTech Innovator, which the largest life science accelerator in the world, X-ZELL is looking to change the world.
For those not in the know, X-ZELL is developing an accurate, affordable, and globally scalable early cancer detection from 10mL blood samples, which is unprecedented. This isn’t their first success at startup programmes and awards, having bagged S$30,000 grant prize from Enterprise Singapore’s Startup SG award.
The startup is based in Singapore, but maintains their global R&D Centre in Bangkok, Thailand.
